Related Experiment Video
Updated: Aug 25, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain
Eunmi Hong1, Joon Shin, Han-Ie Kim
1Department of Biochemistry and Protein Network Research Center, College of Science, Yonsei University, Seoul 120-749, Korea.
Abstract:
Human protein-tyrosine kinase-6 (PTK6, also known as breast tumor kinase (Brk)) is a member of the non-receptor protein-tyrosine kinase family and is expressed in two-thirds of all breast tumors. To understand the structural basis of PTK6 function, we have determined the solution structure and backbone dynamics of the PTK6-Src homology 2 (SH2) domain using multidimensional NMR spectroscopy. The solution structure clearly indicates that the SH2 domain of human PTK6 contains a consensus alpha/beta-fold and a Tyr(P) peptide binding surface, which are common to other SH2 domains. However, two of the alpha-helices (alphaA and alphaB) are located on opposite faces of the central beta-sheet. In addition, the topological arrangement of a central four-stranded antiparallel beta-sheet (strands betaA, betaB, betaC, and betaD) differs from that of other Src family members. Backbone dynamics and Tyr(P) peptide titration experiments revealed that the putative ligand binding sites of the PTK6-SH2 domain undergo distinctive internal motions when compared with other regions of the protein. Surface plasmon resonance analysis showed that the Tyr(P) peptide had a dissociation constant of about 60 microm, which is substantially weaker binding than previously reported for Src family members. The solution structure together with data from the ligand binding mode of PTK6-SH2 provides insight into the molecular basis of the autoinhibitory role of PTK6.
Insights
Human protein-tyrosine kinase-6 (PTK6) SH2 domain structure reveals unique features and weaker binding, offering insights into its autoinhibitory role in breast tumors.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Oncology
Background:
- Human protein-tyrosine kinase-6 (PTK6), also known as breast tumor kinase (Brk), is a non-receptor tyrosine kinase expressed in a majority of breast tumors.
- Understanding the structural basis of PTK6 function is crucial for elucidating its role in cancer.
Purpose of the Study:
- To determine the solution structure and backbone dynamics of the PTK6-Src homology 2 (SH2) domain.
- To investigate the ligand binding properties of the PTK6-SH2 domain.
Main Methods:
- Multidimensional NMR spectroscopy was employed to determine the solution structure and backbone dynamics.
- Peptide titration experiments and surface plasmon resonance analysis were used to study ligand binding.
Main Results:
- The PTK6-SH2 domain adopts a common alpha/beta-fold but exhibits a distinct topological arrangement of its beta-sheet and alpha-helices compared to other Src family members.
- Ligand binding sites showed distinctive internal motions.
- PTK6-SH2 domain demonstrated weaker binding affinity (Kd ~60 μM) for Tyr(P) peptides compared to other Src family members.
Conclusions:
- The unique structural features and weaker ligand binding of the PTK6-SH2 domain provide molecular insights into its autoinhibitory function.
- These findings contribute to understanding PTK6's role in breast tumorigenesis.
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases
Structure of Cadherins
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: